» Articles » PMID: 32758249

Intra-ovarian Injection of Platelet-rich Plasma into Ovarian Tissue Promoted Rejuvenation in the Rat Model of Premature Ovarian Insufficiency and Restored Ovulation Rate Via Angiogenesis Modulation

Overview
Publisher Biomed Central
Date 2020 Aug 8
PMID 32758249
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Premature Ovarian Insufficiency (POI) is viewed as a type of infertility in which the menopausal status occurs before the physiological age. Several therapeutic strategies have been introduced in clinic for POI treatment, although the outputs are not fully convincing. Platelet-rich plasma (PRP) is a unique blood product widely applied in regenerative medicine, which is based on the releasing of the growth factors present in platelets α-granules. In the current investigation, we examined the effectiveness of PRP as a therapeutic alternative for POI animals. POI in Wistar albino rats was induced by daily intraperitoneal (IP) administration of gonadotoxic chemical agent, 4-vinylcyclohexene dioxide (VCD) (160 mg/ kg) for 15 consecutive days. After POI induction, the PRP solution was directly injected intra-ovarian in two concentrations via a surgical intervention. Every two weeks post-injection, pathological changes were monitored in the ovaries using Hematoxylin-Eosin staining method, until eight weeks. Follicle Stimulating Hormone (FSH) content in serum was measured, together with the expression of the angiogenic-related transcripts ANGPT2 and KDR by real-time qPCR. Furthermore the fertility status of the treated rats was evaluated by mating trials. Histopathological examination revealed successful POI induction via the depletion of morphologically normal follicles in rats following VCD treatment compared to the control rats. The injection of PRP at two concentrations reduced the number and extent of the follicular atresia and inflammatory responses (p < 0.05). The expression of both ANGPT2 and KDR transcripts were significantly increased in POI rats due to enhanced inflammation, while these values were modulated after PRP administration (p < 0.05) compared to POI rats. FSH showed a decreased trend in concentration eight weeks after PRP treatment, but not statistically significant (p > 0.05). Nevertheless, a clear improvement in litter counts was found in POI rats receiving PRP compared to the non-treated POI group, being able to consider PRP as a facile, quick, accessible, safe and relatively cheap alternative therapeutic strategy to revert POI-related pathologies.

Citing Articles

CCDC134 enhances ovarian reserve function and angiogenesis by directly interacting with INHA in a mouse model of premature ovarian insufficiency.

Cui X, Li H, Zhu X, Huang X, Xue T, Wang S Apoptosis. 2025; .

PMID: 40042746 DOI: 10.1007/s10495-025-02092-2.


Efficacy and safety of HYYK formula for residual follicle revival in premature ovarian insufficiency: a multicenter, randomized, double-blind, placebo-controlled trial protocol.

Peng Y, Liu J, Li Y, Nie G, Cheng F, Feng D BMC Complement Med Ther. 2025; 25(1):46.

PMID: 39934764 PMC: 11817039. DOI: 10.1186/s12906-025-04803-3.


Novel Advances in Cell-Free Therapy for Premature Ovarian Failure (POF): A Comprehensive Review.

Yahyavi Y, Kheradi N, Karimi A, Ebrahimi-Kalan A, Ramezani F, Yousefi S Adv Pharm Bull. 2024; 14(3):543-557.

PMID: 39494249 PMC: 11530876. DOI: 10.34172/apb.2024.059.


Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis.

Elias M, Konya M, Kekk Z, Turan C, das Virgens I, Toth R J Ovarian Res. 2024; 17(1):104.

PMID: 38760869 PMC: 11100055. DOI: 10.1186/s13048-024-01423-2.


The effect of ovarian response parameters and the synergistic effect of assisted reproduction of poor ovarian response treated with platelet rich plasma: systematic review and meta-analysis.

Li W, Xu J, Deng D BMC Womens Health. 2024; 24(1):263.

PMID: 38678276 PMC: 11055225. DOI: 10.1186/s12905-024-03101-3.


References
1.
Romero-Aleshire M, Diamond-Stanic M, Hasty A, Hoyer P, Brooks H . Loss of ovarian function in the VCD mouse-model of menopause leads to insulin resistance and a rapid progression into the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol. 2009; 297(3):R587-92. PMC: 2739794. DOI: 10.1152/ajpregu.90762.2008. View

2.
Yoshida R, Cheng M, Murray M . Increasing platelet concentration in platelet-rich plasma inhibits anterior cruciate ligament cell function in three-dimensional culture. J Orthop Res. 2013; 32(2):291-5. PMC: 3945668. DOI: 10.1002/jor.22493. View

3.
Zhu S, Hu H, Xu H, Fu X, Peng D, Su W . Human umbilical cord mesenchymal stem cell transplantation restores damaged ovaries. J Cell Mol Med. 2015; 19(9):2108-17. PMC: 4568915. DOI: 10.1111/jcmm.12571. View

4.
Yamaguchi R, Terashima H, Yoneyama S, Tadano S, Ohkohchi N . Effects of platelet-rich plasma on intestinal anastomotic healing in rats: PRP concentration is a key factor. J Surg Res. 2010; 173(2):258-66. DOI: 10.1016/j.jss.2010.10.001. View

5.
Ling L, Feng X, Wei T, Wang Y, Wang Y, Wang Z . Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism. Stem Cell Res Ther. 2019; 10(1):46. PMC: 6347748. DOI: 10.1186/s13287-019-1136-x. View